Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Wockhardt Ltd spurts 8.93%, rises for third straight session
Wockhardt Ltd is quoting at Rs 1552.2, up 8.93% on the day as on 12:49 IST on the NSE. The stock is up 26.12% in last one year as compared to a 1.65% gain in NIFTY and a 9.04% gain in the Nifty Pharma index.

Raja Venkatraman, MarketSmith recommend five stocks for 4 May
After a dip in late April, Indian markets may start positively on May 4, driven by a favourable Gift Nifty. Analysts recommend buying stocks such as Syngene International and DCM Shriram, highlighting their growth potential despite recent market volatility.
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Sensex dives 850 pts, Nifty slips below 24,200 amid oil shock and weak global cues
The equity benchmark indices Sensex and Nifty tumbled on Thursday, extending losses for a second straight session. Firm crude oil prices and ongoing geopolitical tensions rattled sentiment. Brent crude surged for the fourth consecutive day to around $103 per barrel amid uncertainty over US-Iran talks and fresh concerns around the Strait of Hormuz. Weak Asian cues and persistent foreign fund outflows deepened the sell-off. The Nifty slipped below the 24,200 mark, dragged by auto, PSU banks and consumer durables stocks, while pharma and healthcare shares saw selective buying. Investors stayed cautious, closely tracking the ongoing Q4 earnings season for further triggers.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade

JPMorgan downgrades this drugmaker, cuts price target by 19% citing growth challenges
Of the eight analysts who have coverage on the Abbott India stock, six have a 'buy' rating, while one each have 'hold' and 'sell' ratings.
MF Favourites take a hit: 14 smallcap stocks slide up to 50% in 3 months
Despite rising mutual fund stakes, several smallcap stocks have plunged up to 47% in 2026, highlighting market uncertainty and raising questions on whether these beaten-down picks offer value or further downside.
Lupin Ltd down for fifth straight session
Lupin Ltd is quoting at Rs 2255.6, down 0.83% on the day as on 13:19 IST on the NSE. The stock jumped 17.29% in last one year as compared to a 3.17% rally in NIFTY and a 8.74% spurt in the Nifty Pharma index.
Sun Pharmaceutical Industries Ltd eases for fifth straight session
Sun Pharmaceutical Industries Ltd is quoting at Rs 1689.8, down 0.22% on the day as on 13:19 IST on the NSE. The stock jumped 1.41% in last one year as compared to a 3.17% rally in NIFTY and a 8.74% spurt in the Nifty Pharma index.

425% rally in one year! Multibagger stock hits upper circuit on launch of ₹50 million innovation fund
Take Solutions' stock reached a 2% upper circuit at ₹42.04 after announcing a ₹50 million Innovation Fund aimed at investing in AI and health startups. This initiative emphasizes the company's shift towards technology-driven business models to create long-term stakeholder value.

Angel One shares jump 8%, take other capital market peers higher with them
Shares of Angel One had begun trading adjusting for their 1:10 stock split from February 26, when one share of ₹10 was divided into 10 shares of ₹1. Since then, the stock fell 17% to a low of ₹208 on March 13, before recovering.

Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.